Midgard Science

Cerbios-Pharma SA

Barbengo, Switzerland cerbios.swiss

From their website, Nov 2026

Work here? Claim this listing

About

Cerbios-Pharma SA is a pharmaceutical CDMO in Barbengo-Lugano, Switzerland. It develops and manufactures chemical and biological APIs, including HPAPIs, ADCs, recombinant proteins and antibodies, for partners worldwide from preclinical through commercial supply.

Services

  • High Potency APIs

    Develops and manufactures HPAPIs from early stages through clinical trials to commercial supply, including process development, scale-up, containment, and CMC support.

  • Antibody Drug Conjugates

    Develops and manufactures ADCs and their components, including mAbs, payloads/toxins, and conjugation processes from early stage to commercial supply.

    CDMO: development & manufacturing

  • Proteins & Antibodies

    Provides custom development and cGMP production programs for recombinant therapeutic proteins and monoclonal antibodies from cloning to commercial supply.

    Protein production

  • Mammalian cell line and clone generation

    Generates mammalian single clones, including vector generation, transfection, single clone isolation, and RCB generation.

    Cell line development

  • Analytical method development and validation

    Develops, customizes, and validates analytical methods for biotherapeutics, ADCs, and HPAPIs.

  • Formulation development

    Supports formulation studies and development for proteins, antibodies, and ADC drug substances.

  • Stability studies

    Performs ICH stability studies and stability testing for development and registration support.

  • CMC and regulatory support

    Provides CMC regulatory support, including registrations and submissions for product development and commercial supply.

  • Live biotherapeutics

    Supports fermentation, drying, and stabilization of live biotherapeutic products.

    CDMO: development & manufacturing

  • Drug substance manufacturing

    Manufactures drug substances for chemical and biological programs, including recombinant proteins, antibodies, HPAPIs, and ADCs.

    CDMO: development & manufacturing

Capabilities

Assays and studies
ADCs · Antibodies · Process development · Analytical development · Stability studies · HPLC · ELISA · HPLC-SEC · RP-HPLC · HIC · PLRP · CE
9 moreHILIC · nanoDSF · DSC · CIEF · CE-SDS · LC-MS · Potency testing · qPCR · DSF
Scale and capacity
HPAPI batch sizes from 5 grams to 35 kg/batch · HPAPI production units: 5 units fully isolated and contained · HPAPI cGMP unit 10–100 gm/batch · HPAPI cGMP modular units 200 gm–2 kgs/batch · HPAPI cGMP unit 5–35 kgs/batch · HPAPI non-cGMP unit up to 50 gm · Drug product non-cGMP unit up to 100 g · Bioreactors up to 40 L · Cell culture bioreactors up to 100 L upgradable to 500 L · Single-use reactors 5 L–200 L
Therapeutic areas
CNS · Animal health

Instruments and platforms

  • HPLC
  • UPLC-DAD/FLD
  • LC-MS
  • nanoDSF
  • DSC
  • CE-SDS
  • cIEF
  • qPCR
  • High resolution whole well imaging system
  • TFF
  • Bio-Chromatography

Modalities and species

Modalities
Small molecule · Antibody · ADC · Recombinant protein
Species and models
CHO-K1 · CHO-DG44 · PER-C6 · NS0 · mAb · Recombinant proteins

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: cGMP

Company

Type
CRDMO
Founded
1993

Locations

Based in
Barbengo, Switzerland
Sites
Barbengo/Lugano, Switzerland
Serves
worldwide, over 60 countries

Public records

EU GMP certificate (EudraGMDP)
GMPEHV-CH-1008421 source

Similar labs

Work here? Claim this listing